nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—migraine—Prednisone—multiple sclerosis	0.234	0.341	CpDpCtD
Cyclobenzaprine—osteoarthritis—Prednisone—multiple sclerosis	0.226	0.33	CpDpCtD
Cyclobenzaprine—osteoarthritis—Methylprednisolone—multiple sclerosis	0.226	0.33	CpDpCtD
Cyclobenzaprine—CYP2D6—Fingolimod—multiple sclerosis	0.0491	0.261	CbGbCtD
Cyclobenzaprine—CYP3A4—Fingolimod—multiple sclerosis	0.0312	0.166	CbGbCtD
Cyclobenzaprine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0201	0.107	CbGbCtD
Cyclobenzaprine—CYP3A4—Triamcinolone—multiple sclerosis	0.0153	0.0811	CbGbCtD
Cyclobenzaprine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0147	0.078	CbGbCtD
Cyclobenzaprine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0145	0.457	CbGeAlD
Cyclobenzaprine—CYP3A4—Betamethasone—multiple sclerosis	0.0131	0.0695	CbGbCtD
Cyclobenzaprine—CYP3A4—Prednisolone—multiple sclerosis	0.0129	0.0686	CbGbCtD
Cyclobenzaprine—CYP3A4—Prednisone—multiple sclerosis	0.0122	0.0648	CbGbCtD
Cyclobenzaprine—CYP2D6—Dexamethasone—multiple sclerosis	0.012	0.0636	CbGbCtD
Cyclobenzaprine—CYP3A4—Dexamethasone—multiple sclerosis	0.00762	0.0405	CbGbCtD
Cyclobenzaprine—HTR2A—trigeminal nerve—multiple sclerosis	0.00381	0.12	CbGeAlD
Cyclobenzaprine—HTR2A—pons—multiple sclerosis	0.00268	0.0845	CbGeAlD
Cyclobenzaprine—HTR2A—pineal body—multiple sclerosis	0.00191	0.0603	CbGeAlD
Cyclobenzaprine—HTR2A—peripheral nervous system—multiple sclerosis	0.00178	0.0562	CbGeAlD
Cyclobenzaprine—HTR2A—nerve—multiple sclerosis	0.00139	0.0438	CbGeAlD
Cyclobenzaprine—HTR2A—brainstem—multiple sclerosis	0.000597	0.0188	CbGeAlD
Cyclobenzaprine—HTR2A—retina—multiple sclerosis	0.000576	0.0182	CbGeAlD
Cyclobenzaprine—CYP2D6—brainstem—multiple sclerosis	0.000544	0.0171	CbGeAlD
Cyclobenzaprine—HTR2A—medulla oblongata—multiple sclerosis	0.000416	0.0131	CbGeAlD
Cyclobenzaprine—HTR2A—midbrain—multiple sclerosis	0.000381	0.012	CbGeAlD
Cyclobenzaprine—HTR2A—spinal cord—multiple sclerosis	0.000371	0.0117	CbGeAlD
Cyclobenzaprine—HTR2A—nervous system—multiple sclerosis	0.000313	0.00986	CbGeAlD
Cyclobenzaprine—HTR2A—central nervous system—multiple sclerosis	0.000301	0.00949	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellum—multiple sclerosis	0.000294	0.00928	CbGeAlD
Cyclobenzaprine—CYP3A4—nervous system—multiple sclerosis	0.00029	0.00913	CbGeAlD
Cyclobenzaprine—CYP2D6—nervous system—multiple sclerosis	0.000285	0.00898	CbGeAlD
Cyclobenzaprine—CYP3A4—central nervous system—multiple sclerosis	0.000279	0.00879	CbGeAlD
Cyclobenzaprine—CYP2D6—central nervous system—multiple sclerosis	0.000274	0.00865	CbGeAlD
Cyclobenzaprine—CYP2D6—cerebellum—multiple sclerosis	0.000268	0.00845	CbGeAlD
Cyclobenzaprine—HTR2A—brain—multiple sclerosis	0.000239	0.00754	CbGeAlD
Cyclobenzaprine—CYP2D6—brain—multiple sclerosis	0.000218	0.00686	CbGeAlD
Cyclobenzaprine—Shock—Prednisolone—multiple sclerosis	0.000135	0.00144	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000135	0.00144	CcSEcCtD
Cyclobenzaprine—Convulsion—Triamcinolone—multiple sclerosis	0.000134	0.00143	CcSEcCtD
Cyclobenzaprine—Tachycardia—Prednisolone—multiple sclerosis	0.000133	0.00143	CcSEcCtD
Cyclobenzaprine—Convulsion—Methylprednisolone—multiple sclerosis	0.000133	0.00143	CcSEcCtD
Cyclobenzaprine—Hypertension—Triamcinolone—multiple sclerosis	0.000133	0.00143	CcSEcCtD
Cyclobenzaprine—Hypertension—Methylprednisolone—multiple sclerosis	0.000133	0.00142	CcSEcCtD
Cyclobenzaprine—Urticaria—Mitoxantrone—multiple sclerosis	0.000132	0.00142	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000132	0.00142	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000132	0.00141	CcSEcCtD
Cyclobenzaprine—Myalgia—Triamcinolone—multiple sclerosis	0.000131	0.00141	CcSEcCtD
Cyclobenzaprine—Vomiting—Azathioprine—multiple sclerosis	0.000131	0.00141	CcSEcCtD
Cyclobenzaprine—Myalgia—Methylprednisolone—multiple sclerosis	0.000131	0.0014	CcSEcCtD
Cyclobenzaprine—Anxiety—Methylprednisolone—multiple sclerosis	0.00013	0.0014	CcSEcCtD
Cyclobenzaprine—Drowsiness—Methotrexate—multiple sclerosis	0.00013	0.0014	CcSEcCtD
Cyclobenzaprine—Rash—Azathioprine—multiple sclerosis	0.00013	0.00139	CcSEcCtD
Cyclobenzaprine—Dermatitis—Azathioprine—multiple sclerosis	0.00013	0.00139	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00013	0.00139	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00013	0.00139	CcSEcCtD
Cyclobenzaprine—Discomfort—Triamcinolone—multiple sclerosis	0.00013	0.00139	CcSEcCtD
Cyclobenzaprine—Discomfort—Methylprednisolone—multiple sclerosis	0.000129	0.00139	CcSEcCtD
Cyclobenzaprine—Headache—Azathioprine—multiple sclerosis	0.000129	0.00139	CcSEcCtD
Cyclobenzaprine—Dry mouth—Triamcinolone—multiple sclerosis	0.000128	0.00138	CcSEcCtD
Cyclobenzaprine—Angioedema—Betamethasone—multiple sclerosis	0.000128	0.00137	CcSEcCtD
Cyclobenzaprine—Angioedema—Dexamethasone—multiple sclerosis	0.000128	0.00137	CcSEcCtD
Cyclobenzaprine—Stomatitis—Methotrexate—multiple sclerosis	0.000127	0.00136	CcSEcCtD
Cyclobenzaprine—Confusional state—Methylprednisolone—multiple sclerosis	0.000127	0.00136	CcSEcCtD
Cyclobenzaprine—Malaise—Dexamethasone—multiple sclerosis	0.000126	0.00135	CcSEcCtD
Cyclobenzaprine—Malaise—Betamethasone—multiple sclerosis	0.000126	0.00135	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000126	0.00135	CcSEcCtD
Cyclobenzaprine—Oedema—Triamcinolone—multiple sclerosis	0.000126	0.00135	CcSEcCtD
Cyclobenzaprine—Vertigo—Dexamethasone—multiple sclerosis	0.000126	0.00135	CcSEcCtD
Cyclobenzaprine—Vertigo—Betamethasone—multiple sclerosis	0.000126	0.00135	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000126	0.00135	CcSEcCtD
Cyclobenzaprine—Syncope—Dexamethasone—multiple sclerosis	0.000125	0.00135	CcSEcCtD
Cyclobenzaprine—Syncope—Betamethasone—multiple sclerosis	0.000125	0.00135	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Prednisone—multiple sclerosis	0.000125	0.00134	CcSEcCtD
Cyclobenzaprine—Sweating—Methotrexate—multiple sclerosis	0.000125	0.00134	CcSEcCtD
Cyclobenzaprine—Shock—Triamcinolone—multiple sclerosis	0.000124	0.00133	CcSEcCtD
Cyclobenzaprine—Insomnia—Prednisolone—multiple sclerosis	0.000124	0.00133	CcSEcCtD
Cyclobenzaprine—Alopecia—Prednisone—multiple sclerosis	0.000124	0.00133	CcSEcCtD
Cyclobenzaprine—Shock—Methylprednisolone—multiple sclerosis	0.000123	0.00132	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000123	0.00132	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000123	0.00132	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000123	0.00132	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Prednisolone—multiple sclerosis	0.000123	0.00132	CcSEcCtD
Cyclobenzaprine—Tachycardia—Triamcinolone—multiple sclerosis	0.000123	0.00132	CcSEcCtD
Cyclobenzaprine—Nausea—Azathioprine—multiple sclerosis	0.000122	0.00131	CcSEcCtD
Cyclobenzaprine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000122	0.00131	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000122	0.0013	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000122	0.0013	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000121	0.0013	CcSEcCtD
Cyclobenzaprine—Convulsion—Dexamethasone—multiple sclerosis	0.000121	0.0013	CcSEcCtD
Cyclobenzaprine—Convulsion—Betamethasone—multiple sclerosis	0.000121	0.0013	CcSEcCtD
Cyclobenzaprine—Hypertension—Betamethasone—multiple sclerosis	0.000121	0.0013	CcSEcCtD
Cyclobenzaprine—Hypertension—Dexamethasone—multiple sclerosis	0.000121	0.0013	CcSEcCtD
Cyclobenzaprine—Asthenia—Mitoxantrone—multiple sclerosis	0.00012	0.00128	CcSEcCtD
Cyclobenzaprine—Myalgia—Dexamethasone—multiple sclerosis	0.000119	0.00128	CcSEcCtD
Cyclobenzaprine—Myalgia—Betamethasone—multiple sclerosis	0.000119	0.00128	CcSEcCtD
Cyclobenzaprine—Anxiety—Dexamethasone—multiple sclerosis	0.000119	0.00127	CcSEcCtD
Cyclobenzaprine—Anxiety—Betamethasone—multiple sclerosis	0.000119	0.00127	CcSEcCtD
Cyclobenzaprine—Discomfort—Dexamethasone—multiple sclerosis	0.000118	0.00126	CcSEcCtD
Cyclobenzaprine—Discomfort—Betamethasone—multiple sclerosis	0.000118	0.00126	CcSEcCtD
Cyclobenzaprine—Hypotension—Methylprednisolone—multiple sclerosis	0.000117	0.00126	CcSEcCtD
Cyclobenzaprine—Hepatitis—Methotrexate—multiple sclerosis	0.000117	0.00125	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Methotrexate—multiple sclerosis	0.000116	0.00124	CcSEcCtD
Cyclobenzaprine—Vision blurred—Prednisone—multiple sclerosis	0.000115	0.00123	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000115	0.00123	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000114	0.00123	CcSEcCtD
Cyclobenzaprine—Oedema—Dexamethasone—multiple sclerosis	0.000114	0.00122	CcSEcCtD
Cyclobenzaprine—Oedema—Betamethasone—multiple sclerosis	0.000114	0.00122	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000114	0.00122	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000114	0.00122	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000114	0.00122	CcSEcCtD
Cyclobenzaprine—Insomnia—Triamcinolone—multiple sclerosis	0.000114	0.00122	CcSEcCtD
Cyclobenzaprine—Insomnia—Methylprednisolone—multiple sclerosis	0.000114	0.00122	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000113	0.00121	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000113	0.00121	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000113	0.00121	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000113	0.00121	CcSEcCtD
Cyclobenzaprine—Shock—Betamethasone—multiple sclerosis	0.000112	0.0012	CcSEcCtD
Cyclobenzaprine—Shock—Dexamethasone—multiple sclerosis	0.000112	0.0012	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000112	0.0012	CcSEcCtD
Cyclobenzaprine—Agitation—Prednisone—multiple sclerosis	0.000112	0.0012	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000112	0.0012	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000112	0.0012	CcSEcCtD
Cyclobenzaprine—Tachycardia—Dexamethasone—multiple sclerosis	0.000111	0.00119	CcSEcCtD
Cyclobenzaprine—Tachycardia—Betamethasone—multiple sclerosis	0.000111	0.00119	CcSEcCtD
Cyclobenzaprine—Angioedema—Prednisone—multiple sclerosis	0.000111	0.00119	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000111	0.00119	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00011	0.00119	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00011	0.00118	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00011	0.00118	CcSEcCtD
Cyclobenzaprine—Malaise—Prednisone—multiple sclerosis	0.00011	0.00118	CcSEcCtD
Cyclobenzaprine—Vertigo—Prednisone—multiple sclerosis	0.000109	0.00117	CcSEcCtD
Cyclobenzaprine—Syncope—Prednisone—multiple sclerosis	0.000109	0.00117	CcSEcCtD
Cyclobenzaprine—Tinnitus—Methotrexate—multiple sclerosis	0.000109	0.00117	CcSEcCtD
Cyclobenzaprine—Anorexia—Dexamethasone—multiple sclerosis	0.000109	0.00117	CcSEcCtD
Cyclobenzaprine—Anorexia—Betamethasone—multiple sclerosis	0.000109	0.00117	CcSEcCtD
Cyclobenzaprine—Urticaria—Prednisolone—multiple sclerosis	0.000109	0.00117	CcSEcCtD
Cyclobenzaprine—Fatigue—Triamcinolone—multiple sclerosis	0.000108	0.00116	CcSEcCtD
Cyclobenzaprine—Fatigue—Methylprednisolone—multiple sclerosis	0.000108	0.00116	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Prednisone—multiple sclerosis	0.000107	0.00115	CcSEcCtD
Cyclobenzaprine—Hypotension—Dexamethasone—multiple sclerosis	0.000107	0.00114	CcSEcCtD
Cyclobenzaprine—Hypotension—Betamethasone—multiple sclerosis	0.000107	0.00114	CcSEcCtD
Cyclobenzaprine—Vomiting—Mitoxantrone—multiple sclerosis	0.000106	0.00114	CcSEcCtD
Cyclobenzaprine—Convulsion—Prednisone—multiple sclerosis	0.000106	0.00113	CcSEcCtD
Cyclobenzaprine—Hypertension—Prednisone—multiple sclerosis	0.000105	0.00113	CcSEcCtD
Cyclobenzaprine—Rash—Mitoxantrone—multiple sclerosis	0.000105	0.00113	CcSEcCtD
Cyclobenzaprine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000105	0.00113	CcSEcCtD
Cyclobenzaprine—Headache—Mitoxantrone—multiple sclerosis	0.000104	0.00112	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000104	0.00112	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000104	0.00112	CcSEcCtD
Cyclobenzaprine—Myalgia—Prednisone—multiple sclerosis	0.000104	0.00111	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000104	0.00111	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000103	0.00111	CcSEcCtD
Cyclobenzaprine—Anxiety—Prednisone—multiple sclerosis	0.000103	0.00111	CcSEcCtD
Cyclobenzaprine—Alopecia—Methotrexate—multiple sclerosis	0.000103	0.00111	CcSEcCtD
Cyclobenzaprine—Insomnia—Dexamethasone—multiple sclerosis	0.000103	0.00111	CcSEcCtD
Cyclobenzaprine—Insomnia—Betamethasone—multiple sclerosis	0.000103	0.00111	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000103	0.0011	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000102	0.0011	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Betamethasone—multiple sclerosis	0.000102	0.0011	CcSEcCtD
Cyclobenzaprine—Discomfort—Prednisone—multiple sclerosis	0.000102	0.0011	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000101	0.00108	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Betamethasone—multiple sclerosis	0.0001	0.00108	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Dexamethasone—multiple sclerosis	0.0001	0.00108	CcSEcCtD
Cyclobenzaprine—Urticaria—Triamcinolone—multiple sclerosis	9.99e-05	0.00107	CcSEcCtD
Cyclobenzaprine—Urticaria—Methylprednisolone—multiple sclerosis	9.97e-05	0.00107	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Methotrexate—multiple sclerosis	9.97e-05	0.00107	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Prednisone—multiple sclerosis	9.94e-05	0.00107	CcSEcCtD
Cyclobenzaprine—Oedema—Prednisone—multiple sclerosis	9.94e-05	0.00107	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methylprednisolone—multiple sclerosis	9.92e-05	0.00106	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Dexamethasone—multiple sclerosis	9.92e-05	0.00106	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Betamethasone—multiple sclerosis	9.92e-05	0.00106	CcSEcCtD
Cyclobenzaprine—Nausea—Mitoxantrone—multiple sclerosis	9.9e-05	0.00106	CcSEcCtD
Cyclobenzaprine—Fatigue—Betamethasone—multiple sclerosis	9.84e-05	0.00106	CcSEcCtD
Cyclobenzaprine—Fatigue—Dexamethasone—multiple sclerosis	9.84e-05	0.00106	CcSEcCtD
Cyclobenzaprine—Shock—Prednisone—multiple sclerosis	9.78e-05	0.00105	CcSEcCtD
Cyclobenzaprine—Tachycardia—Prednisone—multiple sclerosis	9.7e-05	0.00104	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Prednisone—multiple sclerosis	9.61e-05	0.00103	CcSEcCtD
Cyclobenzaprine—Vision blurred—Methotrexate—multiple sclerosis	9.59e-05	0.00103	CcSEcCtD
Cyclobenzaprine—Anorexia—Prednisone—multiple sclerosis	9.47e-05	0.00102	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Methotrexate—multiple sclerosis	9.44e-05	0.00101	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Dexamethasone—multiple sclerosis	9.4e-05	0.00101	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Betamethasone—multiple sclerosis	9.4e-05	0.00101	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.33e-05	0.001	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.33e-05	0.001	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Triamcinolone—multiple sclerosis	9.27e-05	0.000994	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methylprednisolone—multiple sclerosis	9.25e-05	0.000992	CcSEcCtD
Cyclobenzaprine—Malaise—Methotrexate—multiple sclerosis	9.18e-05	0.000985	CcSEcCtD
Cyclobenzaprine—Vertigo—Methotrexate—multiple sclerosis	9.14e-05	0.000981	CcSEcCtD
Cyclobenzaprine—Leukopenia—Methotrexate—multiple sclerosis	9.11e-05	0.000977	CcSEcCtD
Cyclobenzaprine—Urticaria—Betamethasone—multiple sclerosis	9.07e-05	0.000973	CcSEcCtD
Cyclobenzaprine—Urticaria—Dexamethasone—multiple sclerosis	9.07e-05	0.000973	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.06e-05	0.000971	CcSEcCtD
Cyclobenzaprine—Dizziness—Prednisolone—multiple sclerosis	9.04e-05	0.00097	CcSEcCtD
Cyclobenzaprine—Asthenia—Triamcinolone—multiple sclerosis	9.02e-05	0.000968	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Dexamethasone—multiple sclerosis	9.02e-05	0.000968	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Betamethasone—multiple sclerosis	9.02e-05	0.000968	CcSEcCtD
Cyclobenzaprine—Asthenia—Methylprednisolone—multiple sclerosis	9e-05	0.000966	CcSEcCtD
Cyclobenzaprine—Insomnia—Prednisone—multiple sclerosis	8.99e-05	0.000964	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Prednisone—multiple sclerosis	8.92e-05	0.000957	CcSEcCtD
Cyclobenzaprine—Pruritus—Triamcinolone—multiple sclerosis	8.9e-05	0.000955	CcSEcCtD
Cyclobenzaprine—Pruritus—Methylprednisolone—multiple sclerosis	8.88e-05	0.000952	CcSEcCtD
Cyclobenzaprine—Convulsion—Methotrexate—multiple sclerosis	8.82e-05	0.000946	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Prednisone—multiple sclerosis	8.75e-05	0.000938	CcSEcCtD
Cyclobenzaprine—Myalgia—Methotrexate—multiple sclerosis	8.66e-05	0.000929	CcSEcCtD
Cyclobenzaprine—Chest pain—Methotrexate—multiple sclerosis	8.66e-05	0.000929	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Prednisone—multiple sclerosis	8.64e-05	0.000927	CcSEcCtD
Cyclobenzaprine—Rash—Prednisolone—multiple sclerosis	8.62e-05	0.000925	CcSEcCtD
Cyclobenzaprine—Dermatitis—Prednisolone—multiple sclerosis	8.62e-05	0.000924	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methylprednisolone—multiple sclerosis	8.59e-05	0.000921	CcSEcCtD
Cyclobenzaprine—Fatigue—Prednisone—multiple sclerosis	8.57e-05	0.000919	CcSEcCtD
Cyclobenzaprine—Headache—Prednisolone—multiple sclerosis	8.57e-05	0.000919	CcSEcCtD
Cyclobenzaprine—Discomfort—Methotrexate—multiple sclerosis	8.56e-05	0.000918	CcSEcCtD
Cyclobenzaprine—Constipation—Prednisone—multiple sclerosis	8.5e-05	0.000912	CcSEcCtD
Cyclobenzaprine—Confusional state—Methotrexate—multiple sclerosis	8.38e-05	0.000898	CcSEcCtD
Cyclobenzaprine—Dizziness—Triamcinolone—multiple sclerosis	8.32e-05	0.000892	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methotrexate—multiple sclerosis	8.31e-05	0.000891	CcSEcCtD
Cyclobenzaprine—Dizziness—Methylprednisolone—multiple sclerosis	8.3e-05	0.00089	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Prednisone—multiple sclerosis	8.19e-05	0.000879	CcSEcCtD
Cyclobenzaprine—Asthenia—Dexamethasone—multiple sclerosis	8.19e-05	0.000878	CcSEcCtD
Cyclobenzaprine—Asthenia—Betamethasone—multiple sclerosis	8.19e-05	0.000878	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Methotrexate—multiple sclerosis	8.13e-05	0.000872	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Prednisone—multiple sclerosis	8.13e-05	0.000872	CcSEcCtD
Cyclobenzaprine—Nausea—Prednisolone—multiple sclerosis	8.12e-05	0.000871	CcSEcCtD
Cyclobenzaprine—Pruritus—Dexamethasone—multiple sclerosis	8.07e-05	0.000866	CcSEcCtD
Cyclobenzaprine—Pruritus—Betamethasone—multiple sclerosis	8.07e-05	0.000866	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methotrexate—multiple sclerosis	8.03e-05	0.000861	CcSEcCtD
Cyclobenzaprine—Vomiting—Triamcinolone—multiple sclerosis	8e-05	0.000858	CcSEcCtD
Cyclobenzaprine—Vomiting—Methylprednisolone—multiple sclerosis	7.98e-05	0.000856	CcSEcCtD
Cyclobenzaprine—Rash—Triamcinolone—multiple sclerosis	7.93e-05	0.000851	CcSEcCtD
Cyclobenzaprine—Dermatitis—Triamcinolone—multiple sclerosis	7.92e-05	0.00085	CcSEcCtD
Cyclobenzaprine—Anorexia—Methotrexate—multiple sclerosis	7.92e-05	0.000849	CcSEcCtD
Cyclobenzaprine—Rash—Methylprednisolone—multiple sclerosis	7.91e-05	0.000849	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methylprednisolone—multiple sclerosis	7.91e-05	0.000848	CcSEcCtD
Cyclobenzaprine—Urticaria—Prednisone—multiple sclerosis	7.9e-05	0.000847	CcSEcCtD
Cyclobenzaprine—Headache—Triamcinolone—multiple sclerosis	7.88e-05	0.000845	CcSEcCtD
Cyclobenzaprine—Headache—Methylprednisolone—multiple sclerosis	7.86e-05	0.000843	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Prednisone—multiple sclerosis	7.86e-05	0.000843	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Dexamethasone—multiple sclerosis	7.81e-05	0.000838	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Betamethasone—multiple sclerosis	7.81e-05	0.000838	CcSEcCtD
Cyclobenzaprine—Hypotension—Methotrexate—multiple sclerosis	7.76e-05	0.000833	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.57e-05	0.000812	CcSEcCtD
Cyclobenzaprine—Dizziness—Betamethasone—multiple sclerosis	7.55e-05	0.00081	CcSEcCtD
Cyclobenzaprine—Dizziness—Dexamethasone—multiple sclerosis	7.55e-05	0.00081	CcSEcCtD
Cyclobenzaprine—Insomnia—Methotrexate—multiple sclerosis	7.51e-05	0.000806	CcSEcCtD
Cyclobenzaprine—Nausea—Triamcinolone—multiple sclerosis	7.47e-05	0.000801	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methotrexate—multiple sclerosis	7.46e-05	0.0008	CcSEcCtD
Cyclobenzaprine—Nausea—Methylprednisolone—multiple sclerosis	7.45e-05	0.0008	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Methotrexate—multiple sclerosis	7.41e-05	0.000794	CcSEcCtD
Cyclobenzaprine—Somnolence—Methotrexate—multiple sclerosis	7.38e-05	0.000792	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Prednisone—multiple sclerosis	7.32e-05	0.000785	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methotrexate—multiple sclerosis	7.31e-05	0.000784	CcSEcCtD
Cyclobenzaprine—Vomiting—Betamethasone—multiple sclerosis	7.26e-05	0.000778	CcSEcCtD
Cyclobenzaprine—Vomiting—Dexamethasone—multiple sclerosis	7.26e-05	0.000778	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Methotrexate—multiple sclerosis	7.22e-05	0.000775	CcSEcCtD
Cyclobenzaprine—Rash—Dexamethasone—multiple sclerosis	7.2e-05	0.000772	CcSEcCtD
Cyclobenzaprine—Rash—Betamethasone—multiple sclerosis	7.2e-05	0.000772	CcSEcCtD
Cyclobenzaprine—Dermatitis—Betamethasone—multiple sclerosis	7.19e-05	0.000771	CcSEcCtD
Cyclobenzaprine—Dermatitis—Dexamethasone—multiple sclerosis	7.19e-05	0.000771	CcSEcCtD
Cyclobenzaprine—Fatigue—Methotrexate—multiple sclerosis	7.16e-05	0.000768	CcSEcCtD
Cyclobenzaprine—Headache—Dexamethasone—multiple sclerosis	7.15e-05	0.000767	CcSEcCtD
Cyclobenzaprine—Headache—Betamethasone—multiple sclerosis	7.15e-05	0.000767	CcSEcCtD
Cyclobenzaprine—Asthenia—Prednisone—multiple sclerosis	7.13e-05	0.000765	CcSEcCtD
Cyclobenzaprine—Pruritus—Prednisone—multiple sclerosis	7.03e-05	0.000754	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methotrexate—multiple sclerosis	6.84e-05	0.000734	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Prednisone—multiple sclerosis	6.8e-05	0.000729	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.79e-05	0.000729	CcSEcCtD
Cyclobenzaprine—Nausea—Betamethasone—multiple sclerosis	6.78e-05	0.000727	CcSEcCtD
Cyclobenzaprine—Nausea—Dexamethasone—multiple sclerosis	6.78e-05	0.000727	CcSEcCtD
Cyclobenzaprine—Urticaria—Methotrexate—multiple sclerosis	6.6e-05	0.000708	CcSEcCtD
Cyclobenzaprine—Dizziness—Prednisone—multiple sclerosis	6.57e-05	0.000705	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methotrexate—multiple sclerosis	6.57e-05	0.000704	CcSEcCtD
Cyclobenzaprine—Vomiting—Prednisone—multiple sclerosis	6.32e-05	0.000678	CcSEcCtD
Cyclobenzaprine—Rash—Prednisone—multiple sclerosis	6.27e-05	0.000672	CcSEcCtD
Cyclobenzaprine—Dermatitis—Prednisone—multiple sclerosis	6.26e-05	0.000672	CcSEcCtD
Cyclobenzaprine—Headache—Prednisone—multiple sclerosis	6.23e-05	0.000668	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methotrexate—multiple sclerosis	6.12e-05	0.000656	CcSEcCtD
Cyclobenzaprine—Asthenia—Methotrexate—multiple sclerosis	5.96e-05	0.000639	CcSEcCtD
Cyclobenzaprine—Nausea—Prednisone—multiple sclerosis	5.9e-05	0.000633	CcSEcCtD
Cyclobenzaprine—Pruritus—Methotrexate—multiple sclerosis	5.88e-05	0.00063	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methotrexate—multiple sclerosis	5.68e-05	0.00061	CcSEcCtD
Cyclobenzaprine—Dizziness—Methotrexate—multiple sclerosis	5.49e-05	0.000589	CcSEcCtD
Cyclobenzaprine—Vomiting—Methotrexate—multiple sclerosis	5.28e-05	0.000567	CcSEcCtD
Cyclobenzaprine—Rash—Methotrexate—multiple sclerosis	5.24e-05	0.000562	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methotrexate—multiple sclerosis	5.23e-05	0.000561	CcSEcCtD
Cyclobenzaprine—Headache—Methotrexate—multiple sclerosis	5.2e-05	0.000558	CcSEcCtD
Cyclobenzaprine—Nausea—Methotrexate—multiple sclerosis	4.93e-05	0.000529	CcSEcCtD
